The Royal Institute of British Architects (RIBA) has announced a shortlist of architects who will progress to the next phase of design for The Fleming Centre at St Mary’s Hospital.
This follows the RIBA design competition launched in collaboration with Imperial College Healthcare NHS Trust in July.
The evaluation panel has selected the following practices to proceed to the next phase of the competition:
- AHMM
- Allies and Morrison
- Grimshaw
- Stanton Williams
- Wilkinson Eyre and White Arkitekter
The shortlisted teams will now enter the next phase of the process, with a final decision expected to be announced in January 2025.
The shortlisted teams will now enter the next phase of the process, with a final decision expected to be announced in January 2025
The Fleming Centre will be at the heart of the global Fleming Initiative, an innovative and collaborative approach led by the Trust and Imperial College London, with HRH Prince of Wales as its Patron, to tackle anti-microbial resistance (AMR).
Further, the Fleming Centre will be a key part of the Trust’s Paddington Life Sciences development which is creating a thriving ecosystem for life sciences research and innovation with St Mary’s as its hub.
In turn, Paddington Life Sciences is an integral part of the Imperial WestTech Corridor, a globally significant concentration of technology and innovation stretching across west London acting as a catalyst for investment, employment, and inclusive growth.
The Fleming Centre will also be part of a global network of centres in strategic locations around the world, aiming to catalyse worldwide action.
St Mary’s Hospital – along with the Trust’s two other main sites, Charing Cross and Hammersmith hospitals – are part of the government’s New Hospital Programme
In terms of funding, Lord Darzi of Denham, Executive Chair of the Fleming Initiative, last week, announced it had raised an initial £100m, supported by three new partners, LifeArc, Cepheid and Optum, alongside founding partner, GSK, and other philanthropists.
The Centre is due to open at St Mary’s Hospital in 2028, helping to mark the centenary of the discovery of penicillin at the hospital by Sir Alexander Fleming.
St Mary’s Hospital – along with the Trust’s two other main sites, Charing Cross and Hammersmith hospitals – are part of the government’s New Hospital Programme.
The Fleming Centre will be the first new building to open at St Mary’s as part of plans for the redevelopment of the whole hospital site over the next decade.
The Trust is proposing to build a new 800-bed hospital at the east of the estate
The Trust submitted a first-stage business case to the government’s New Hospital Programme in 2021 for a full redevelopment of St Mary’s and is currently awaiting a decision on funding to progress detailed design and town planning work.
The Trust is proposing to build a new 800-bed hospital at the east of the estate.
Chief Executive of Imperial College Healthcare NHS Trust, Professor Tim Orchard, said: "We are excited by the prospect of plans for the Fleming Centre that incorporate creative ways to honour the legacy of Sir Alexander Fleming. We will be engaging with staff, patients and local communities to ensure that the Fleming Centre brings real impact, locally and globally, as a visionary space for collaboration, groundbreaking science and engagement to drive change."
